Two genes (tetC and tetD) were identified and located on transposon TnlO between gene tetA and insertion sequence ISIOR. Genes teiC and tetD encode proteins of apparent subunit molecular weights of 23,000 and 18,000, respectively. The TetD protein was found to be membrane associated. Tetracycline resistance levels promoted by transposon TnlO were found to be unaffected in Escherichia coli K-12 when mutants lacking teiC or teiC and tetD were tested. The nucleotide sequence of genes teiC and tetD is reported in the accompanying article (K. Schollmeier and W. Hillen, J. Bacteriol. 160: [499] [500] [501] [502] [503] 1984) .
Transposon TnJO, with a total length of 9,300 base pairs (bp), consists of a core region of unique sequence flanked by the 1,300-bp insertion sequences IS10L and ISIOR in inverted orientation (11) . Within the core region, comprising 6,700 bp, two genes, tetA and tetR, have been identified (5, 12, 15, 31) . These genes are transcribed in a divergent manner from a common control region and code for proteins whose synthesis is inducible by tetracycline (5, 15, 31) . The gene product of tetA (apparent molecular weight, 36,000) has been shown to be essential for tetracycline resistance; tetR encodes a repressor protein (apparent molecular weight, 23,000) (5, 15, 31) . Together, these two genes, located on the IS10R side of the core region, comprise a length of 1,900 bp ( Fig. 1) . The expression of two additional proteins of unknown functions has been attributed to TnJO, although no genes for these proteins have so far been identified. The synthesis of one of these proteins (molecular weight, 15,000) was found to be inducible by tetracycline (32) , whereas the synthesis of the second polypeptide (molecular weight, 13,000) was not affected by the antibiotic (33) .
Jorgenson and Reznikoff (15) presented data that indicated that a region of TnJO, now known to comprise genes tetA and tetR, is sufficient for the expression of inducible tetracycline resistance. Higher levels of induced and uninduced resistance were, however, observed when mutants lacking DNA sequences distal to tetA were tested, implying that genes affecting the expression of tetracycline resistance are located on DNA sequences between tetA and ISIOR (15) .
Here we report the identification of two genes, tetC and tetD, located on TnJO between tetA and ISIOR. Deletion of these genes had no effect on the level of tetracycline resistance encoded by the transposon in Escherichia coli K-
12.
MATERIALS from Amersham Corp. 2-Acetyl-2-decarboxyamide tetracycline was a gift of Pfizer Inc. The media used have been described previously (5) .
Bacterial strains and plasmids. The bacterial strains used are derivatives of E. coli K-12. All enzyme measurements were done with plasmid carrying derivatives of CB454 A(lacZ-lacY+) thi rpsL recA56 galK, a galK mutant of CB40 (5) . Resistance determinations were carried out with strain W4680 (5). The minicell-producing strain 312a is a recA derivative of strain P678-54 (1) described by Rak and von Reutem (25) . The plasmids used are listed in Table 1 .
Enzymes. The following restriction endonucleases were purchased from Bethesda Research Laboratories: HindIll, BgIII, PstI, HincII, and EcoRI. T4 DNA ligase was obtained from Boehringer Mannheim.
Preparation of DNA and transformation. Plasmid DNA was prepared from 1-or 800-ml cultures grown in LB medium (5) by the procedures of Birnboim and Doly (7) . DNA from the 800-ml cultures was purified by an ethidium bromide-cesium chloride gradient (29) . Transformation was carried out as described by Lederberg and Cohen (20) .
Gel electrophoresis of DNA. The buffer system and staining of the gels were as described previously (5) . Horizontal agarose gel electrophoresis employed agarose concentrations ranging from 0.7 to 1.6%. DNA fragments were isolated after electroelution essentially as described by Wienand et al. (30) .
Plasmid constructions. For the construction of plasmid pCB144, plasmid pCB8 was completely digested with PstI and partially digested with HindIII. A 15-kilobase DNA fragment, comprising all of pCB8 except the DNA between the right HindIII restriction site within the TnJO core region and the PstI site, was isolated and ligated in the presence of a 38-bp HindIII-PstI linker fragment isolated from the polylinker region of pFD51.
Plasmid pCB149 was constructed in two steps. First, in a subclone of pCB8 that lacked all TnJO sequences between the outside border of ISIOL and tetA (pCB27 [5] ), the 320-bp HindIII-BglII fragment neighboring ISIOR was replaced by a 640-bp A DNA fragment isolated from pKB166 (3) after digestion with HindlIl and BglII. From a clone containing the insert, a 3.1-kb HindIII-PstI DNA fragment which comprised ISIOR was isolated and ligated into the 15-kb pCB8 DNA fragment generated by digestion with PstI and HindIII (partial) as described above.
Galactokinase assay. We used the galactokinase assay conditions described by Rak and von Reutern (25) . Preparation and labeling of minicells. Derivatives of minicell-producing strain 312A harboring plasmids were grown with aeration in 300 ml of LB at 37°C until the stationary phase. Minicells were isolated in two steps. First, whole cells were separated from minicells by centrifugation in a Sorvall RC-2 centrifuge (rotor GS3, 4,000 rpm for 15 min). Minicells were pelleted (Sorvall RC-2 centrifuge, rotor GS3, 8,000 rpm for 35 min) and suspended in buffer (10 mM Trishydrochloride [pH 7.4], 150 mM NaCI). Further purification of minicells was carried out by centrifugation through continuous sucrose gradients as described by Reeve (26) . Minicells were suspended in AB medium supplemented with 0.4% glycerol and 20 ,ug of cycloserine per ml to an absorbancy at 578 nm of 1. To the minicell suspension (0.5 ml) a mixture of amino acids (containing all except methionine) was added to a final concentration of 0.22 mM and, this suspension was incubated at 37°C for 30 min. Labeling of proteins was initiated by adding 100 p.Ci of [35S]methionine (specific activity, 1,400 Ci/mmol) and continued for 45 min at 37°C. Induction was performed by the addition of the non- (18) . The samples-containing about 40,000 cpm each-were electrophoresed through a 10 to 20% acrylamide gradient slab gel with a 5% stacking gel at a constant voltage of 300 V for 12 h. The gels were stained and destained as described by Schumacher and Bussmann (28) . Bovine serum albumin (molecular weight, 66,000), ovalbumin (45,000), chymotrypsin (25,000), myoglobin (17,800), cytochrome c (12,900), and trypsin inhibitor (6,500) were used as molecular weight standards. Fluorography was carried out as described by Chamberlain (8) (4, 5) . In an extension of these studies we isolated several fusion mutants in which the deletions extended from the outside border of ISIOL to various sites within the TnJO DNA segment delimited by the BglII and HindIII restriction sites neighboring ISIOR ( Fig. 1; data not shown) . From these data we drew the tentative conclusion that a gene (or part of it) must be located between these two restriction sites. Since lacZ was located next to ISIOL, the direction of transcription of this gene pointed in the direction of ISIOL. These initial observations were verified and extended by the ligation of distinct DNA fragments of TnJO in front of the galactokinase structural gene (galK) on the pKO1-derived promoter detection plasmid pFD51 (25) . The structures of these plasmids are shown in Fig. 2 . The DNA fragment comprising the right end of TnJO (including ISIOR) was isolated after digestion of pCB8 with restriction endonucleases EcoRI and HindIII and ligated into pFD51 digested with EcoRI and HindIII, resulting in plasmid pCB111. Transformation of pCB111 into CB454 (galK recA) resulted in clones that produced galactokinase (Table 2 ). Since the HindIll site of the TnJO core region was located next to the galactokinase structural gene, we concluded that the DNA segment at this HindlIl site is transcribed in vivo with the orientation from IS10R toward the tetA gene. The following constructions were carried out to define the promoter more precisely. We isolated the 320-bp BglII-HindIII TnJO DNA fragment of pCB8 located between tetA and ISIOR ( Fig. 1) and ligated it into pFD51 deleted for the BglII-HindIII fragment. Plasmid pCB120 contained the BglII-HindIII fragment with the HindIlI site located next to galK (Fig. 2) with pCB120 did not result in the production of galactokinase (Table 2) , and we concluded that this BglII-HindIII DNA fragment does not harbor a promoter transcribing in the direction from ISIOR toward the tetA gene. The tentative conclusion that the origin of the transcription activity observed with pCB110 was located between ISIOR and its neighboring BglII site was tested by ligating the isolated EcoRI-BglII fragment of pCB8 (including ISIOR; Fig. 1 ) into plasmid pFD51 deleted for the EcoRI-BgIII fragment. In the resulting plasmid, pCB110, the EcoRI-BglII fragment was inserted with the BglII site neighboring galK (Fig. 2) . CB454 harboring plasmid pCB110 produced galactokinase. The transcriptional activities observed at the ISIOR neighboring BglII and Hindll sites thus originated from the same promoter that we presume to be located between ISIOR and the BglII site. From these data as well as from the results obtained with protein fusion mutants we concluded that a gene, which we named tetC, is located between tetA and ISIOR on TnWO and that the direction of transcription of this gene is toward ISIOL (Fig. 1) .
The teiC gene codes for a protein of 23,000 daltons. Analysis of the DNA sequence in the region where we had mapped the tetC gene revealed an open reading frame, ORFL (27) Fig. 4 . The results clearly demonstrate that the TetD protein was associated with the membrane fraction. Other proteins encoded by pCB143 served as internal controls for the fractionation: galactokinase, 1-lactamase precursor, and mature ,-lactamase were found in the cytoplasm, membrane, and periplasm, respectively.
Phenotypes of mutants defective in tetC and tetD. To test the effect of genes tetC and tetD on the expression of TnJOencoded tetracycline resistance, deletion mutants lacking tetC or tetC and tetD were generated by in vitro techniques.
Using pCB8 (with complete TnJO) as starting material, we constructed two types of mutants. (i) tetC-deletion mutants were obtained by replacement of the 320-bp BglII-HindIII DNA fragment on the right side of TnJO (Fig. 1) by a BglIIHindIll DNA fragment containing part of the lambda cI gene isolated from plasmid pKB166 (3). This construction yielded plasmid pCB149 (Fig. 1). (ii) tetC tetD deletion mutants were generated by replacement of the HindIII-PstI DNA fragment of pCB8 by a 38-bp HindIII-PstI DNA fragment obtained from the linker fragment of pFD51, resulting in plasmid pCB144 (Fig. 1) .
The levels of tetracycline resistance generated in isogenic strains by pCB8 (with intact TnWO), pCB149 (tetC-), and pCB144 (tetC-tetD-) are given in Table 3 . TnWO on miniColEl-derived plasmid pCB8 caused levels of resistance approximately 150% higher than those conferred by a single TnJO on the chromosome of an isogenic strain (data not shown) and thus, with the strain employed, did not exhibit the multicopy effect (10, 22) , i.e., a reduction in resistance due to the presence of TnJO on a multicopy vector. Deletion of tetC or tetC and tetD did not affect levels of resistance of cells grown with (induced) or without (uninduced) tetracycline (Table 3) . From these results we concluded that in E. coli K-12 tetC and tetD have no evident function in TnJOencoded tetracycline resistance. Using plasmids containing only tetC and tetD, we tested whether these two genes together were able to confer resistance on the host strain. No increase in tetracycline resistance was observed.
DISCUSSION
We identified two genes, tetC and tetD, on transposon TnJO and located them on a DNA segment between gene tetA and ISIOR (Fig. 1) . The orientation of tetC was found to be opposite to that of tetA, pointing toward IS10L. Gene tetD is located between tetC and ISIOR. Evidence obtained by cloning tetC gene fragments in front of the galK structural gene suggested that the promoter for tetC is located between the right BglII restriction site of the TnJO core region and ISIOR. A promoter of correct orientation was located in this region by in vitro methods (27) . Analysis of the DNA sequence of this region of TnJO (27) revealed an open reading frame that may code for a protein of 22 The expression of tetC is rather weak, as can be seen by inspectipn of the band corresponding to TetC protein on the autoradiogram (Fig. 3) and from the data obtained with tetCgalK fusions ( Table 2 ). The level of galactokinase activity encoded by multicopy plasmid pCB111 corresponds to about 60% of the enzyme activity, which could be determined from the chromosomal copy of galK when the gal operon was induced (data not shown). Higher levels of tetC expression were consistently observed with strains harbouring pCB110, in which galK was fused to the beginning of tetC. Whether the difference in enzyme activity observed between pCB110 and pCB111 reflects some intrinsic properties of the tetC gene or is due to differences in DNA sequence between the fusion points of tetC and the translational start signal of galK is unknown.
Judging from the intensity of the band corresponding to the TetD protein on the autoradiogram, minicells harboring an intact TnJO synthesize only small amounts of this protein even in the presence of the non-inhibitory inducer of genes tetA and tetR, 2-acetyl-2-decarboxyamide tetracycline (Fig.  3, track d) . Expression of tetD in minicells was substantially increased by the addition of 2-acetyl-2-decarboxyamide tetracycline when plasmid pCB111-which contains a tetC gene (altered in the region coding for the carboxy end of the protein), but lacks other sequences of the TnlO core regionwas tested (compare tracks b and c of Fig. 3 ). These data are consistent with the assumption that the synthesis of the TetD protein is regulated. The details of the regulatory system controlling the expression of tetD remain to be elucidated.
Levels of tetracycline resistance encoded in E. coli K-12 by TnJO were found to be unaffected by the presence or (5), and the structures of the plasmids are presented in Fig. 1. bTetracycline resistance is expressed as 50% efficiency of plating (i.e., the tetracycline concentration [in micrograms per milliliter] that resulted ip a 50% reduction in CFU. Resistance levels were determined as described previously (5) . absence of these genes. Since they are maiptained on TnJO in a functional state, the question arises as to their function. In considering this question, it must be kept in mind that the core region on the ISIOL side of TnJO contains 2,700 bp of unknown genetic structure and function. The possibility that genes tetC and tetD and the 2,700 bp next to IS10L have no function in the tetracycline resistance mechanism cnanot at present be excluded. The inducibility of gene tetD by a tetracycline derivative suggests a role of these genes in tetracycline resistance. Possibly, the additional genetic information present on TnJO is of importance for the expression of resistance in various groups of gram-negative bacteria other than E. coli K-12. A core region considerably larger than required for genes tetA and tetR (4,500 to 6,500 bp) has also been determined on various tetracycline resistance transposons isolated from gram-negative bacteria (6, 14, 16, 17) . Although functions have so far not been identified on these extra DNA sequences, it is tempting to speculate that they may contain genetic information that is of selective advantage. Work is in progress to investigate the function of these sequences.
